NEW YORK (GenomeWeb News) – The Diamantina Institute at the University of Queensland will use IO Informatics’ software in its cancer research programs, the company said today.
The institute, which is situated at the Princess Alexandra Hospital in Brisbane, Australia, will use the company’s Sentient Life Science software suite in its efforts
“Our goal is to identify genes involved in common cancers such as cervical, breast, skin and prostate cancer,” Diamantina Deputy Director Tom Gonda said in a statement. Those studies require that the researchers “pull data and information from a cornucopia of sources, such as genomics, proteomics, high throughput analytical instruments and internet accessible databases,” and Sentient “answers that need,” he said.
Financial terms of the agreement were not released.
IO Informatics also recently formed an Informatics for Personalized Medicine Working Group aimed at creating partnerships with pharmaceutical companies, doctors, hospitals, and research institutes.